Dr Dunn leads a discussion outlining frontline therapies for the treatment of vitiligo. Jeffrey D. Dunn, PharmD, MBA: What therapies are being used? Are they generally covered by different books of ...

The MarketWatch News Department was not involved in the creation of this content. HORSHAM, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ: SSKN) ...

Experts provide closing pearls regarding the current and prospective treatment landscape of vitiligo. Jeffrey D. Dunn, PharmD, MBA: This has been an awesome discussion. Before we conclude, I’d like to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Therapy using a 308 nm laser was ...

On July 18, the U.S. Food and Drug Administration (FDA) approved ruxolitinib (Opzelura) cream 1.5 percent as a treatment for the most common form of vitiligo, according to a statement by Incyte, the ...

Last spring, Dominick was at a golf tournament with some friends watching some of the golfers on the putting green. A woman behind him made a comment about how ugly his skin was and that he probably ...

MCLEAN, VA / ACCESSWIRE / September 11, 2024 / Dr. Amir Bajoghli and the Skin & Laser Dermatology Center provide effective treatment options for patients with vitiligo, a skin condition characterized ...

Edesa Biotech, Inc. (NASDAQ:EDSA) is planning for a Phase 2 study of its anti-CXCL10 monoclonal antibody for the treatment of moderate-to-severe non-segmental vitiligo patients. Vitiligo is a disease ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc., developer and manufacturer of the PHAROS EX-308 Excimer Laser for psoriasis and vitiligo announced today that it had record sales and was ...